Biology subjects

Hasan, R.

Publications and source records attributed to Hasan, R..

15 recordsLinked to original sources

bioRxiv2026

Serial intravascular labeling resolves dynamic decidual NK residency and gestational remodeling toward T-bet-Low states

Decidual natural killer (dNK) cells are the predominant immune population at the maternal-fetal interface during early pregnancy. However, how vascular trafficking, tissue residency, proliferation, and apoptosis-associated activity are coordinated to establish and maintain the dNK population throughout pregnancy remains unclear. We hypothesized that gestational remodeling of the dNK compartment reflects coordinated changes in these cellular processes in association with progressive T-bet downregulation. We combined serial intravascular labeling (SIVL), flow cytometry, BrdU incorporation, active caspase-3 detection, spatial imaging, and Tbx21 fate mapping to examine NK cells in virgin mice and across gestation. Pregnancy altered CD49a/CD49b-defined dNK-cell composition and redistributed dNK cells among SIVL-defined vascular-accessibility states, supporting a model of dynamic dNK-cell tissue residency. Trafficking-associated marker scores displayed continuous gradients of tissue retention, circulatory/egress potential, and chemokine responsiveness rather than defining a single resident state. Spatial imaging demonstrated greater dNK-cell density in the mesometrial decidua and preferential CD31 vessel contact by recently intravascular dNK cells during early and mid-gestation. BrdU incorporation and active caspase-3 positivity peaked during early pregnancy and varied across SIVL-defined states. Tbx21 fate mapping identified a progressive and selective shift from current T-bet expression toward ex-T-bet and non-fate-mapped Eomes dNK states. T-bet-low states preferentially maintained proliferation at mid-gestation, whereas current T-bet expression was associated with greater circulatory/egress potential. However, active caspase-3 was not selectively increased in current T-bet-expressing cells. Collectively, these findings identify pregnancy-induced dNK-cell remodeling as a coordinated process integrating dynamic tissue residency, vascular accessibility, local proliferation, and apoptosis-associated activity, alongside a progressive shift toward T-bet-low dNK states.

immunology↗

bioRxiv2026

Natural Variation in Maize Shikimate Dehydrogenase Alters Enzyme Activity and Kernel Homoserine Accumulation.

Metabolic diversity in maize kernels determines nutritional quality and end-use value. Therefore, understanding its genetic basis is essential for crop improvement and elucidating plant metabolic regulation. Here, we integrated metabolite profiling with metabolite-based genome-wide association studies (mGWAS), structural modeling, enzyme kinetics, and genome-scale metabolic simulations to identify genetic determinants of kernel metabolite variation in 265 maize inbred lines. Profiling of 57 metabolites revealed inter-genotypic variation, with homoserine among the most variable metabolites. mGWAS identified 62 locus-trait associations implicating 788 candidate genes, including 154 encoding metabolic enzymes. A major association for homoserine mapped to the shikimate dehydrogenase gene Sad1 on chromosome 10. Four tightly linked coding-region SNPs, including three non-synonymous variants, defined two Sad1 haplotypes associated with differential homoserine accumulation, independent of gene expression variation. Structural analysis and recombinant enzyme assays showed that these substitutions occur within catalytic and cofactor-binding domains and alter catalytic efficiency. Genome-scale metabolic modeling indicated that variation in SAD1 activity influences plastidial oxaloacetate availability for aspartate and homoserine biosynthesis through redox-coupled flux via the malate-oxaloacetate shuttle. Together, our results indicate that Sad1 allelic variation alters enzyme function and amino acid accumulation, linking the shikimate pathway, redox metabolism, and amino acid biosynthesis in maize kernels.

plant biology↗

bioRxiv2025

A Portable RPA-CRISPR/Cas12a-Based Biosensing Platform for On-Site Detection of the Microcystin Synthetase E Gene in Lake Water

Microcystins are potent cyanotoxins produced by toxigenic cyanobacteria during harmful algal blooms (HABs), posing risks to ecosystems and human health. In this study, we developed a portable RPA-CRISPR/Cas12a biosensing platform for the rapid, on-site detection of the microcystin synthetase E (mcyE) gene, a key biomarker for microcystin-producing strains. The developed RPA-CRISPR/Cas12a assays enable detection of the mcyE gene within 50 min, with either fluorescence or lateral flow assay readouts. The fluorescence readouts have an analytical detection limit of 48.4 copies/{micro}L and a dynamic range of 1.2 x 102 to 1.2 x 107 copies/{micro}L. To enable field deployment, a magnetic bead-based DNA extraction method was integrated, achieving extraction within 1 hour without centrifugation. The complete workflow demonstrated a method LOD of 8.4 x 102 cells/mL in spiked lake water. Applicability was validated using non-spiked environmental water samples collected from multiple HAB-affected lakes. Importantly, a systematic matrix effect assessment was conducted for the CRISPR sensing step, evaluating environmental variables such as pH, ions, nutrients, and natural organic matter. This study establishes a practical, sensitive, and selective detection tool for proactive HAB monitoring. The platforms simplicity, portability, and completeness, from sample pretreatment to signal readout, highlight its potential for real-world environmental biosensing applications.

microbiology↗

bioRxiv2025

CTx001 for geographic atrophy: a gene therapy expressing soluble, truncated complement receptor 1 (mini-CR1)

Over-activation of the complement system is strongly associated with geographic atrophy (GA), a late-stage form of age-related macular degeneration (AMD) and major cause of blindness. Here we report the development of a candidate GA treatment that is a potent complement modifier (mini-CR1) that addresses consequences of complement over-activation including membrane attack complex (MAC) formation. Mini-CR1 acts a potent cofactor for factor I driven proteolysis of C3b leading to iC3b and then C3dg formation; iC3b itself remains a potent opsonin. As well as inhibiting the alternative complement pathway, mini-CR1 acts as a cofactor for C4b degradation thereby inhibiting the classical pathway. Mini-CR1 prevents MAC formation in activated human serum with an IC50 of 125 nM. Mini-CR1 was shown to cross human Bruchs membrane ex vivo, implying the ability to cross into the choroidal space. Transduction of RPE cell lines with rAAV2-mini-CR1 (CTx001) resulted in dose-dependent transcription, and both basolateral and apical secretion of mini-CR1 by monolayers of human iPSC derived RPE cells. Mini-CR1 transduction of ARPE19 cells resulted in increased consumption of C3b and iC3b1 in activated culture media and decreased MAC formation on the cell surfaces. Subretinal injection of CTx001 in rats resulted in dose-dependent mini-CR1 production as demonstrated by solid-phase immunoassay. MAC formation following laser induced CNV in a rat model was reduced by 75% in CTx001-treated animals relative to null vector (p<0.01). This first generation of CTx001 represents a potent single administration complement modifier capable of effectively addressing pathologic complement amplification in the retina/choroid.

biochemistry↗

bioRxiv2024

Identification and characterization of a wet adhesive protein extracted from Dreissena bugensis, the freshwater quagga mussel

Mechanisms of wet adhesion have been developed by several aquatic organisms over millions of years of evolutionary processes. Yet, the repertoire of synthetic biocompatible wet adhesive materials is still limited. In most marine bioadhesive proteins, 3,4-dihydroxyphenylalanine (DOPA) plays a significant role in strong interfacial interactions. The bioadhesive proteins in freshwater organisms are less well understood. The quagga mussel (Dreissena bugensis) is a notorious freshwater invasive species in the Great Lakes that attaches to a plethora of surfaces via a byssus. To determine the adhesive proteins in the quagga mussel byssus, we utilized quantitative proteomics to identify the proteins enriched at the byssus-substrate interface. Among the identified proteins was the Dbfp7 protein family. Dbfp7 is a small, polymorphic, and mostly disordered protein that lacks significant amounts of DOPA. Atomic force microscopy measurements of Dbfp7 confirm that this protein has similar adhesion energy to marine mussel adhesive proteins in aqueous conditions despite lacking DOPA. These results suggest that freshwater mussels may employ different mechanisms of adhesion compared to marine byssates. The inclusion of Dbfp7 to the library of known wet bioadhesive proteins - the first functionally characterized freshwater bioadhesive protein to our knowledge - will allow for a better understanding of the fundamental properties required to achieve biocompatible wet adhesion, a crucial step for the development of bio-inspired wet adhesive materials, such as improved medical adhesives. Significance StatementWhile many aquatic organisms evolved strategies to adhere to surfaces underwater, current synthetic biocompatible adhesives lack reliable adhesive strength in varying aqueous conditions. Investigating freshwater mussel adhesive proteins expands the current understanding of aquatic bioadhesion and offers potential advancements in wet adhesive technology. The discovery of a DOPA-deficient wet adhesive protein derived from the invasive quagga mussels presents a paradigm shift to the currently known mechanisms of byssal bioadhesion, thereby expanding the repertoire of wet adhesive strategies. Further, understanding the mechanism of adhesion employed by this biofouling species can help with the design of anti-fouling strategies to mitigate the impacts of these animals on the infrastructure and ecosystems in the Great Lakes and connected freshwater systems in North America.

biochemistry↗

bioRxiv2023

A Versatile Tool for Precise Variant Calling in Mycobacterium tuberculosis Genetic Polymorphisms

BackgroundWhole genome sequencing (WGS) facilitates the diagnosis of multidrug-resistant MDR-TB through the interpretation of sequence variations (SV) in Mycobacterium tuberculosis (MTB) genes. Information on phenotypic and genotypic resistance associations continues to evolve, it is important to identify SV within genes of interest. We developed an MTB-VCF variant calling pipeline that can compare against the reference genome for any gene of interest. We demonstrate its utility for calling SV in genes associated with Rifampicin (RIF), Isoniazid (INH), Ethambutol (EM), and Streptomycin (SM) resistance. MethodsMTB-VCF is a Python-based command line Variant Calling pipeline designed to streamline batch processing from raw reads (FastQ) files. SV called by MTB-VCF were compared with those identified by TBProfiler, KVARQ, CASTB, Mykrobe Predictor and Phy-ResSE pipelines. The sensitivity and Specificity of MTB-VCF SV calling were calculated against the drug susceptibility testing (DST) phenotype. ResultsMTB-VCF identified 868 SV present in 200 phenotypically resistant MDR-TB isolates. These were across rpsl, rrs, rpoB, inhA, katG, ahpC, gidB and embCAB genes. Of these, 684 SV were known to be associated with a resistance genotype, leading to a specificity of 97.75%. The SV called by the MTB-VCF was compared separately to resistance genotypes called by TB-Profiler, KvarQ, CASTB, Mykrobe Predictor, and PhyRes-SE pipelines, demonstrating a sensitivity of 99.5%. ConclusionThe MTB-VCF pipeline offers a rapid and accurate solution for identifying SV in target genes for interpretation later. It can be run in large batches, proving flexible computing that allows for the customization of core bioinformatic pipelines, enabling the analysis of WGS data from different technologies.

bioinformatics↗

bioRxiv2023

Gene Therapy Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice

Aging is a complex process best characterized as the chronic dysregulation of cellular processes leading to deteriorated tissue and organ function. While aging cannot currently be prevented, its impact on lifespan and healthspan in the elderly can potentially be minimized by interventions that aim to return these cellular processes to optimal function. Recent studies have demonstrated that partial reprogramming using the Yamanaka factors (or a subset; OCT4, SOX2, and KLF4; OSK) can reverse age-related changes in vitro and in vivo. However, it is still unknown whether the Yamanaka factors (or a subset) are capable of extending the lifespan of aged wild type mice. Here, we show that systemically delivered AAVs, encoding an inducible OSK system, in 124-week-old mice extends the median remaining lifespan by 109% over wild-type controls and enhances several health parameters. Importantly, we observed a significant improvement in frailty scores indicating that we were able to improve the healthspan along with increasing the lifespan. Furthermore, in human keratinocytes expressing exogenous OSK, we observed significant epigenetic markers of age-reversal, suggesting a potential reregulation of genetic networks to a younger, potentially healthier state. Together, these results may have important implications for the development of partial reprogramming interventions to reverse age-associated diseases in the elderly.

bioengineering↗

bioRxiv2022

Brain DNA methylomic analysis of frontotemporal lobar degeneration reveals OTUD4 and CEBPZ in shared dysregulated signatures across pathological subtypes

Frontotemporal lobar degeneration (FTLD) is an umbrella term describing the neuropathology of a clinically, genetically and pathologically heterogeneous group of diseases, including frontotemporal dementia (FTD) and progressive supranuclear palsy (PSP). Among the major FTLD pathological subgroups, FTLD with TDP-43 positive inclusions (FTLD-TDP) and FTLD with tau positive inclusions (FTLD-tau) are the most common, representing about 90% of the cases. Although alterations in DNA methylation have been consistently associated with neurodegenerative diseases, including Alzheimers disease and Parkinsons disease, little is known for FTLD and its heterogeneous subgroups and subtypes. The main goal of this study was to investigate DNA methylation variation in FTLD-TDP and FTLD-tau. We used frontal cortex genome-wide DNA methylation profiles from three FTLD cohorts (234 individuals), generated using the Illumina 450K or EPIC microarray. We performed epigenome-wide association studies (EWAS) for each cohort followed by meta-analysis to identify shared differential methylated loci across FTLD subgroups/subtypes. Additionally, we used weighted gene correlation network analysis to identify co-methylation signatures associated with FTLD and other disease-related traits. Wherever possible, we also incorporated relevant gene/protein expression data. After accounting for a conservative Bonferroni multiple testing correction, the EWAS meta-analysis revealed two differentially methylated loci in FTLD, one annotated to OTUD4 (5UTR-shore) and the other to NFATC1 (gene body-island). Of these loci, OTUD4 showed consistent upregulation of mRNA and protein expression in FTLD. Additionally, in the three independent co-methylation networks, OTUD4-containing modules were enriched for EWAS meta-analysis top loci and were strongly associated with the FTLD status. These co-methylation modules were enriched for genes implicated in the ubiquitin system, RNA/stress granule formation and glutamatergic synaptic signalling. Altogether, our findings identified novel FTLD-associated loci, and support a role for DNA methylation as a mechanism involved in the dysregulation of biological processes relevant to FTLD, highlighting novel potential avenues for therapeutic development.

neuroscience↗

bioRxiv2022

Reversal of lactate and PD-1-mediated macrophage immunosuppression controls growth of PTEN/p53-deficient prostate cancer

PTEN loss-of-function occurs in approximately 50% of mCRPC patients, and is associated with a poor prognosis, therapeutic outcomes and resistance to immune-checkpoint inhibitors. Recent clinical studies demonstrated that dual PI3K/AKT pathway inhibition and androgen axis blockade led to a modest improvement in progression-free survival of PTEN-deficient mCRPC patients, but the mechanistic basis for this limited efficacy is unknown. To elucidate potential resistance mechanism(s), we performed co-clinical trials in a prostate-specific PTEN/p53-deficient genetically-engineered mouse model, and discovered that the recruitment of PD-1-expressing tumor-associated macrophages (TAM) thwarts the phagocytosis-mediated anti-tumor efficacy of androgen deprivation therapy (ADT)/PI3K inhibitor (PI3Ki) combination. Strikingly, we observed a TAM-dependent [~]3-fold enhancement in the overall response rate with the addition of PD-1 antibody (aPD-1) to ADT/PI3Ki combination therapy. Mechanistically, decreased lactate production from PI3Ki-treated tumor cells suppressed histone lactylation (H3K18lac) within TAM, resulting in their phagocytic activation, which was augmented by concurrent ADT/aPD-1 treatment. Consistent with our murine observations, single cell RNA-sequencing analysis of human metastatic PC samples revealed a direct correlation between high glycolytic activity and phagocytosis suppression. Critically, feedback activation of Wnt/{beta}-catenin signaling observed in non-responder mice following ADT/PI3Ki/aPD-1 combination treatment, restored lactate-mediated H3K18lac and suppressed phagocytosis within macrophages. Altogether, these data suggest that reversal of lactate and PD-1-mediated TAM immunosuppression by PI3Ki and aPD-1, respectively, controls tumor growth in combination with ADT, and warrants further clinical investigation in PTEN/p53-deficient mCRPC patients. One Sentence SummaryInhibition of tumor-cell intrinsic lactate production suppresses PTEN/p53-deficient prostate cancer growth via macrophage activation/phagocytosis

cancer biology↗

bioRxiv2021

A plasma membrane-localized polycystin-1/polycystin-2 complex in endothelial cells elicits vasodilation

Polycystin-1 (PC-1, PKD1), a receptor-like protein expressed by the Pkd1 gene, is present in a wide variety of cell types, but its cellular location, signaling mechanisms and physiological functions are poorly understood. Here, by studying tamoxifen-inducible, endothelial cell (EC)-specific Pkd1 knockout (Pkd1 ecKO) mice, we show that flow activates PC-1-mediated, Ca2+-dependent cation currents in ECs. EC-specific PC-1 knockout attenuates flow-mediated arterial hyperpolarization and vasodilation. PC-1-dependent vasodilation occurs over the entire functional shear stress range and primarily via the activation of nitric oxide synthase (NOS), with a smaller contribution from small-conductance Ca2+-activated K+ (SK) channels. EC-specific PC-1 knockout increases systemic blood pressure without altering kidney anatomy. PC-1 coimmunoprecipitates with polycystin-2 (PC-2, PKD2), a TRP polycystin channel, and clusters of both proteins locate in nanoscale proximity in the EC plasma membrane. Knockout of either PC-1 or PC-2 (Pkd2 ecKO mice) abolishes surface clusters of both PC-1 and PC-2 in ECs. Single knockout of PC-1 or PC-2 or double knockout of PC-1 and PC-2 (Pkd1/Pkd2 ecKO mice) similarly attenuates flow-mediated vasodilation. Flow stimulates non-selective cation currents in ECs that are similarly inhibited by either PC-1 or PC-2 knockout or by interference peptides corresponding to the C-terminus coiled-coil domains present in PC-1 or PC-2. In summary, we show that PC-1 regulates arterial contractility and demonstrate that this occurs through the formation of an interdependent signaling complex with PC-2 in endothelial cells. Flow stimulates PC-1/PC-2 clusters in the EC plasma membrane, leading to Ca2+ influx, NOS and SK channel activation, vasodilation and a reduction in blood pressure.

physiology↗

bioRxiv2021

Molecular evolution and genetic analysis of Mesta yellow vein mosaic virus and associated betasatellites

Mesta yellow vein mosaic disease (MYVMD), one of the major diseases circulating mesta growing regions of Indian sub-continent, is responsible for serious yield loss in mesta crops. A complex of monopartite begomovirus, Mesta yellow vein mosaic virus (MYVMV) and associated betasatellite, is reported in several studies as the causal agent of MYVMD. However, all-inclusive molecular evolutionary analysis of so far available MYVMVs and associated betasatellites disseminating in this region is still lacking. In this study, by estimating and analyzing various indexes of population genetics and evolutionary parameters, we discussed the sources of genetic variations, population dynamics and different forces acting on the evolution of MYVMVs and associated betasatellites. The study finds recombination as a vital force in the evolution and diversification of begomovirus complexes in different geographic locations however, betasatellites were found to be exposed to more diverse recombination events compared to MYVMVs. Indian isolates are reported to have high frequency of polymorphism in this study which suggests a balancing selection or expansion occurring in Indian populations of begomoviruses. Higher degree of genetic differentiation and lower rate of gene flow calculated between the viral populations of Bangladesh and Pakistan is justified by the relatively far geographical distance between these two countries. Although the study detects overall purifying selection, the degrees of constraints acting on individual gene tested are found different. Coat protein (AV1) is estimated with very high nucleotide substitution rate which is very likely to result from the strongest purifying selection pressure (dN/dS = 0.131) calculated in this study on coat protein. The findings of this study on different evolutionary forces that shape the emergence and diversification of MYVMVs and associated betasatellites may provide directions towards future evolutionary trend analysis and development of comprehensive disease control strategies for begomoviruses.

evolutionary biology↗

bioRxiv2020

Host range projection of SARS-CoV-2: South Asia perspective

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causing agent of Coronavirus Disease-2019 (COVID-19), is likely to be originated from bat and transmitted through intermediate hosts. However, the immediate source species of SARS-CoV-2 has not yet been confirmed. Here, we used diversity analysis of the angiotensin I converting enzyme 2 (ACE2) that serves as cellular receptor for SARS-CoV-2 and transmembrane protease serine 2 (TMPRSS2), which has been proved to be utilized by SARS-CoV-2 for spike protein priming. We also simulated the structure of receptor binding domain of SARS-CoV-2 spike protein (SARS-CoV-2 S RBD) with the ACE2s to investigate their binding affinity to determine the potential intermediate animal hosts that could spread the SARS-CoV-2 virus to humans in South Asia. We identified cow, buffalo, goat and sheep, which are predominant species in the household farming system in South Asia that can potentially be infected by SARS-CoV-2. All the bird species studied along with rat and mouse were considered less potential to interact with SARS-CoV-2. The interaction interfaces of SARS-CoV-2 S RBD and ACE2 protein complex suggests pangolin as a potential intermediate host in SARS-CoV-2. Our results provide a valuable resource for the identification of potential hosts for SARS-CoV-2 in South Asia and henceforth reduce the opportunity for a future outbreak of COVID-19.

molecular biology↗

bioRxiv2020

SARS-CoV-2 genome analysis of strains in Pakistan reveals GH, S and L clade strains at the start of the pandemic

ObjectivesPakistan has a high infectious disease burden with about 265,000 reported cases of COVID-19. We investigated the genomic diversity of SARS-CoV-2 strains and present the first data on viruses circulating in the country. MethodsWe performed whole-genome sequencing and data analysis of SARS-CoV-2 eleven strains isolated in March and May. ResultsStrains from travelers clustered with those from China, Saudi Arabia, India, USA and Australia. Five of eight SARS-CoV-2 strains were GH clade with Spike glycoprotein D614G, Ns3 gene Q57H, and RNA dependent RNA polymerase (RdRp) P4715L mutations. Two were S (ORF8 L84S and N S202N) and three were L clade and one was an I clade strain. One GH and one L strain each displayed Orf1ab L3606F indicating further evolutionary transitions. ConclusionsThis data reveals SARS-CoV-2 strains of L, G, S and I have been circulating in Pakistan from March, at the start of the pandemic. It indicates viral diversity regarding infection in this populous region. Continuing molecular genomic surveillance of SARS-CoV-2 in the context of disease severity will be important to understand virus transmission patterns and host related determinants of COVID-19 in Pakistan.

genomics↗

bioRxiv2019

Islet macrophages drive islet remodeling and compensatory hyperinsulinemia in the early diabetes

{beta}-cells respond to peripheral insulin resistance by increasing circulating insulin in early type-2 diabetes (T2D). Islet remodeling supports this compensation but the drivers of this process remain poorly understood. Infiltrating macrophages have been implicated in late stage T2D but relatively little is known on islet resident macrophages, especially in early T2D. We hypothesize that islet resident macrophages contribute to islet vascular remodeling and hyperinsulinemia, the failure of which results in a rapid progression to T2D. Using genetic and diet-induced models of compensatory hyperinsulinemia we show that its depletion significantly compromises islet remodeling in terms of size, vascular density and insulin secretion capacity. Depletion of islet macrophages reduces VEGF-A secretion from both human and mouse islets ex vivo and the impact of reduced VEGF-A functionally translates to delayed re-vascularization upon transplantation in vivo. Hence, we show a new role of islet resident macrophages in the context of early T2D and suggest that there is considerable utility in harnessing islet macrophages to promote islet remodeling and islet insulin secretion capacity.\n\nHighlightsO_LIThe compensatory hyperinsulinemic phase of type-2 diabetes is accompanied with significant pancreatic islet remodeling.\nC_LIO_LIBona fide islet resident macrophages are increased during the diabetic compensation phase by largely in situ proliferation.\nC_LIO_LIAblating macrophages severely compromises the islet remodeling process and exacerbates glycemic control in vivo.\nC_LIO_LIMouse and human islet macrophages contribute VEGF-A to the islet environment.\nC_LIO_LISpecific removal of islet macrophages delays islet vascularization in compensatory hyperinsulinemic mice.\nC_LI

molecular biology↗

bioRxiv2018

Arterial smooth muscle cell PKD2 (TRPP1) channels control systemic blood pressure

Systemic blood pressure is determined, in part, by arterial smooth muscle cells (myocytes). Several Transient Receptor Potential (TRP) channels are proposed to be expressed in arterial myocytes, but it is unclear if these proteins control physiological blood pressure and contribute to hypertension in vivo. We generated the first inducible, smooth muscle-specific knockout for a TRP channel, namely for PKD2 (TRPP1), to investigate arterial myocyte and blood pressure regulation by this protein. Using this model, we show that intravascular pressure and 1-receptors activate PKD2 channels in arterial myocytes of different systemic organs. PKD2 channel activation in arterial myocytes leads to an inward Na+ current, membrane depolarization and vasoconstriction. Inducible, smooth muscle cell-specific PKD2 knockout lowers both physiological blood pressure and hypertension and prevents pathological arterial remodeling during hypertension. In summary, we show for the first time that arterial myocyte PKD2 channels control systemic blood pressure and targeting reduces high blood pressure.

neuroscience↗